2026 Q1 Portfolio Activity
In 2026 Q1, Tri Locum Partners LP maintained a portfolio of 21 distinct positions. The most significant new addition was INTUITIVE SURGICAL INC, now representing 9.91% of the total fund value. They heavily accumulated shares in DEXCOM INC, increasing the position by 65.6%. Conversely, Tri Locum Partners LP completely exited their position in DANAHER CORPORATION.
Position History
hover any row below to update
Loading…
Total Positions
21
Quarter
2026 Q1
Top Holding
JNJ (14.2%)
Top 10 Concentration
81.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-21 of 21
Tri Locum Partners LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
JNJ
JOHNSON & JOHNS...
|
Healthcare | 14.22% | 16.21% |
#1
Prev: #1
|
6.0 |
—
|
-188,640 | -31.3% |
P
S
|
414,503 | $101,321,113 |
$179.68
+30.4%
|
2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | ||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 9.91% | — |
#2
Prev: #—
|
9.0 |
—
|
153,250 | — |
NEW
|
153,250 | $70,646,718 |
$454.20
-3.5%
|
2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-18 | ||
|
TMO
THERMO FISHER S...
|
Healthcare | 9.13% | — |
#3
Prev: #—
|
8.2 |
—
|
132,413 | — |
NEW
|
132,413 | $65,084,962 |
$501.07
-10.3%
|
2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | ||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 8.20% | 7.34% |
#4
1
Prev: #5
|
4.3 |
—
|
-9,683 | -3.7% |
P
S
|
255,332 | $58,402,088 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 8.10% | — |
#5
Prev: #—
|
7.2 |
—
|
129,314 | — |
NEW
|
129,314 | $57,743,874 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 7.98% | 8.83% |
#6
3
Prev: #3
|
3.7 |
—
|
-1,489 | -2.4% |
P
S
|
61,795 | $56,837,187 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 7.59% | 6.50% |
#7
1
Prev: #6
|
5.5 |
—
|
17,265 | 20.1% |
P
S
|
103,288 | $54,068,169 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
DXCM
DEXCOM INC
|
Healthcare | 6.15% | 3.63% |
#8
6
Prev: #14
|
5.5 |
—
|
276,558 | 65.6% |
P
S
|
698,158 | $43,844,322 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 5.86% | 7.65% |
#9
5
Prev: #4
|
2.3 |
—
|
-50,551 | -41.8% |
P
S
|
70,370 | $41,728,003 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
NUVL
NUVALENT INC
|
Healthcare | 4.44% | 4.01% |
#10
3
Prev: #13
|
2.3 |
—
|
1,135 | 0.4% |
P
S
|
308,506 | $31,606,440 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
TEVA
TEVA PHARMACEUT...
|
Healthcare | 4.32% | 5.82% |
#11
3
Prev: #8
|
1.7 |
—
|
-414,857 | -28.9% |
P
S
|
1,021,008 | $30,752,761 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 4.21% | — |
#12
Prev: #—
|
5.2 |
—
|
158,663 | — |
NEW
|
158,663 | $29,995,240 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
ARGX
ARGENX SE
|
Healthcare | 3.24% | 4.11% |
#13
1
Prev: #12
|
1.8 |
—
|
-6,018 | -16.0% |
P
S
|
31,635 | $23,101,459 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 2.49% | — |
#14
Prev: #—
|
4.5 |
—
|
252,588 | — |
NEW
|
252,588 | $17,719,048 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.71% | 3.33% |
#15
Prev: #15
|
0.7 |
—
|
-476,860 | -76.6% |
P
S
|
145,543 | $12,213,969 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 1.47% | 4.78% |
#16
5
Prev: #11
|
0.6 |
—
|
-139,511 | -69.2% |
P
S
|
62,116 | $10,498,846 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 0.98% | — |
#17
Prev: #—
|
3.9 |
—
|
369,588 | — |
NEW
|
369,588 | $6,985,213 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 0.00% | 5.30% |
Sold All 😨
(Was: #10) |
0.0 |
—
|
-805,689 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.00% | 5.72% |
Sold All 😨
(Was: #9) |
0.0 |
—
|
-557,174 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 0.00% | 6.44% |
Sold All 😨
(Was: #7) |
0.0 |
—
|
-520,508 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 | |||
|
DHR
DANAHER CORPORA...
|
Healthcare | 0.00% | 10.31% |
Sold All 😨
(Was: #2) |
0.0 |
—
|
-346,875 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-18 |
Showing 1-21 of 21 holdings